Transcriptional regulation by nonclassical action of thyroid hormone

Thyroid Research

Volumn 4, Issue SUPPL. 1, 2011, Pages

  Moeller, Lars C ^a   Broecker Preuss, Martina ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79961193866     PISSN: None     EISSN: 17566614     Source Type: Journal    
DOI: 10.1186/1756-6614-4-S1-S6     Document Type: Review

References (36)

1. Physiological and molecular basis of thyroid hormone action. PM Yen, Physiol Rev 2001 81 3 1097 142 11427693 (Pubitemid 32606667)
2. Molecular aspects of thyroid hormone actions. SY Cheng JL Leonard PJ Davis, Endocr Rev 2010 31 2 139 170 20051527
3. Resistance to thyroid hormone. RE Weiss S Refetoff, Rev Endocr Metab Disord 2000 1 1-2 97 108 11704998
4. Molecular basis of resistance to thyroid hormone. PM Yen, Trends Endocrinol Metab 2003 14 7 327 333 10.1016/S1043-2760(03)00114-0 12946875 (Pubitemid 37093130)
5. Familial syndrome combining deaf-mutism, stuppled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormone. S Refetoff LT DeWind LJ DeGroot, J Clin Endocrinol Metab 1967 27 2 279 294 10.1210/jcem-27-2-279 4163616
6. Recessive inheritance of thyroid hormone resistance caused by complete deletion of the protein-coding region of the thyroid hormone receptor-beta gene. K Takeda A Sakurai LJ DeGroot S Refetoff, J Clin Endocrinol Metab 1992 74 1 49 55 10.1210/jc.74.1.49 1727829
7. Isoform-specific transcriptional activity of overlapping target genes that respond to thyroid hormone receptors alpha1 and beta1. IH Chan ML Privalsky, Mol Endocrinol 2009 23 11 1758 1775 10.1210/me.2009-0025 19628582
8. Physiological thyroid hormone levels regulate numerous skeletal muscle transcripts. WE Visser KA Heemstra SM Swagemakers Z Ozgur EP Corssmit J Burggraaf WF van Ijcken PJ van der Spek JW Smit TJ Visser, J Clin Endocrinol Metab 2009 94 9 3487 3496 10.1210/jc.2009-0782 19567520
9. Thyroid hormone responsive genes in cultured human fibroblasts. LC Moeller AM Dumitrescu RL Walker PS Meltzer S Refetoff, J Clin Endocrinol Metab 2005 90 2 936 943 15507505 (Pubitemid 40279219)
10. Hepatic gene expression patterns in thyroid hormone-treated hypothyroid rats. JM Weitzel S Hamann M Jauk M Lacey A Filbry C Radtke KA Iwen S Kutz A Harneit PM Lizardi HJ Seitz, J Mol Endocrinol 2003 31 2 291 303 10.1677/jme.0.0310291 14519097 (Pubitemid 37321580)
11. Thyroid hormone-regulated mouse cerebral cortex genes are differentially dependent on the source of the hormone: a study in monocarboxylate transporter-8- and deiodinase-2-deficient mice. B Morte A Ceballos D Diez C Grijota-Martinez AM Dumitrescu C Di Cosmo VA Galton S Refetoff J Bernal, Endocrinology 2010 151 5 2381 2387 10.1210/en.2009-0944 20211971
12. Thyroid hormone regulation of hepatic genes in vivo detected by complementary DNA microarray. X Feng Y Jiang P Meltzer PM Yen, Mol Endocrinol 2000 14 7 947 955 10.1210/me.14.7.947 10894146 (Pubitemid 32250513)
13. Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts. X Cao F Kambe LC Moeller S Refetoff H Seo, Mol Endocrinol 2005 19 1 102 112 15388791 (Pubitemid 40065962)
14. 3,3',5-Triiodo-L-thyronine up-regulation of Na,K-ATPase activity and cell surface expression in alveolar epithelial cells is Src kinase- and phosphoinositide 3-kinase-dependent. J Lei CN Mariash DH Ingbar, J Biol Chem 2004 279 46 47589 600 10.1074/jbc.M405497200 15342623 (Pubitemid 39540904)
15. Rac and Rho mediate opposing hormonal regulation of the ether-a-go-go-related potassium channel. NM Storey JP O'Bryan DL Armstrong, Curr Biol 2002 12 1 27 33 10.1016/S0960-9822(01)00625-X 11790300 (Pubitemid 34063350)
16. Rapid signaling at the plasma membrane by a nuclear receptor for thyroid hormone. NM Storey S Gentile H Ullah A Russo M Muessel C Erxleben DL Armstrong, Proc Natl Acad Sci U S A 2006 103 13 5197 5201 10.1073/pnas.0600089103 16549781
17. Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone beta receptor. F Furuya JA Hanover SY Cheng, Proc Natl Acad Sci U S A 2006 103 6 1780 5 10.1073/pnas.0510849103 16446424 (Pubitemid 43228770)
18. Thyroid-hormone-dependent activation of the phosphoinositide 3-kinase/Akt cascade requires Src and enhances neuronal survival. X Cao F Kambe M Yamauchi H Seo, Biochem J 2009 424 2 201 209 10.1042/BJ20090643 19747164
19. Rapid nongenomic actions of thyroid hormone. Y Hiroi HH Kim H Ying F Furuya Z Huang T Simoncini K Noma K Ueki NH Nguyen TS Scanlan MA Moskowitz SY Cheng JK Liao, Proc Natl Acad Sci U S A 2006 103 38 14104 14109 10.1073/pnas.0601600103 16966610 (Pubitemid 44452987)
20. Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. JJ Bergh HY Lin L Lansing SN Mohamed FB Davis S Mousa PJ Davis, Endocrinology 2005 146 7 2864 2871 10.1210/en.2005-0102 15802494 (Pubitemid 41002793)
21. Pro-angiogenesis action of thyroid hormone and analogs in a three-dimensional in vitro microvascular endothelial sprouting model. SA Mousa FB Davis S Mohamed PJ Davis X Feng, Int Angiol 2006 25 4 407 413 17164749 (Pubitemid 46351000)
22. Membrane Receptor for Thyroid Hormone: Physiologic and Pharmacologic Implications. PJ Davis FB Davis SA Mousa MK Luidens HY Lin, Annu Rev Pharmacol Toxicol 2011 10 51 99 115 20868274
23. L-Thyroxine vs. 3,5,3'-triiodo-L-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. HY Lin M Sun HY Tang C Lin MK Luidens SA Mousa S Incerpi GL Drusano FB Davis PJ Davis, Am J Physiol Cell Physiol 2009 296 5 980 91 10.1152/ajpcell.00305.2008 19158403
24. Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells. FB Davis HY Tang A Shih T Keating L Lansing A Hercbergs RA Fenstermaker A Mousa SA Mousa PJ Davis HY Lin, Cancer Res 2006 66 14 7270 5 10.1158/0008-5472.CAN-05-4365 16849576 (Pubitemid 44197708)
25. Thyroid hormone is a MAPK-dependent growth factor for thyroid cancer cells and is anti-apoptotic. HY Lin HY Tang A Shih T Keating G Cao PJ Davis FB Davis, Steroids 2007 72 2 180 187 10.1016/j.steroids.2006.11.014 17174366 (Pubitemid 46273502)
26. Molecular cloning of a novel thyroid hormone-responsive gene, ZAKI-4, in human skin fibroblasts. T Miyazaki Y Kanou Y Murata S Ohmori T Niwa K Maeda H Yamamura H Seo, J Biol Chem 1996 271 24 14567 14571 10.1074/jbc.271.24.14567 8662924 (Pubitemid 26190362)
27. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. GL Semenza, Oncogene 2010 29 5 625 634 10.1038/onc.2009.441 19946328
28. Cytosolic action of thyroid hormone leads to induction of hypoxia-inducible factor-1alpha and glycolytic genes. LC Moeller AM Dumitrescu S Refetoff, Mol Endocrinol 2005 19 12 2955 2963 10.1210/me.2004-0542 16051672 (Pubitemid 41697714)
29. Human stanniocalcin-1 interacts with nuclear and cytoplasmic proteins and acts as a SUMO E3 ligase. MT Dos Santos DM Trindade KD Goncalves GC Bressan F Anastassopoulos JA Yunes J Kobarg, Mol Biosyst 2011 7 1 180 193 21042649
30. Identification and characterization of the hypoxia-responsive element in human stanniocalcin-1 gene. AY Law LY Ching KP Lai CK Wong, Mol Cell Endocrinol 2010 314 1 118 127 10.1016/j.mce.2009.07.007 19628018
31. Stanniocalcin 1 Induction by Thyroid Hormone Depends on Thyroid Hormone Receptor beta and Phosphatidylinositol 3-kinase Activation. LC Moeller NE Haselhorst AM Dumitrescu X Cao H Seo S Refetoff K Mann OE Janssen, Exp Clin Endocrinol Diabetes. 2011 119 2 81 85 20827662
32. Triiodothyronine utilizes phosphatidylinositol 3-kinase pathway to activate anti-apoptotic myeloid cell leukemia-1. M Pietrzak M Puzianowska-Kuznicka, J Mol Endocrinol 2008 41 3 177 186 10.1677/JME-08-0010 18552129
33. Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface. FB Davis SA Mousa L O'Connor S Mohamed HY Lin HJ Cao PJ Davis, Circ Res 2004 94 11 1500 6 10.1161/01.RES.0000130784.90237.4a 15117822 (Pubitemid 38780323)
34. Tetraidothyroacetic acid (tetrac) and tetrac nanoparticles inhibit growth of human renal cell carcinoma xenografts. M Yalcin DJ Bharali L Lansing E Dyskin SS Mousa A Hercbergs FB Davis PJ Davis SA Mousa, Anticancer Res 2009 29 10 3825 3831 19846915
35. Tetraiodothyroacetic acid (tetrac) and nanoparticulate tetrac arrest growth of medullary carcinoma of the thyroid. M Yalcin E Dyskin L Lansing DJ Bharali SS Mousa A Bridoux AH Hercbergs HY Lin FB Davis GV Glinsky A Glinskii J Ma PJ Davis SA Mousa, J Clin Endocrinol Metab 2010 95 4 1972 1980 10.1210/jc.2009-1926 20133461
36. Thyroid hormone mediated changes in gene expression can be initiated by cytosolic action of the thyroid hormone receptor beta through the phosphatidylinositol 3-kinase pathway. LC Moeller X Cao AM Dumitrescu H Seo S Refetoff, Nucl Recept Signal 2006 4 020 16862226